CLINICAL_TRIALS
trial_result
· 2021-09-23
Clinical Trial Update: Study of the Safety and Tolerability of AXA1957 in Adolescent Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD) [NA]
Summary
Clinical trial update for AXA1957 in adolescents with NAFLD; study terminated with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Axcella Health, Inc | Conditions: NAFLD | NA | Status: TERMINATED | Results posted: 2021-09-23